Table 1: Baseline characteristics of the patients.

CharacteristicClassificationNumber of patients (%)

No23 (20.2)
Pretreatment drugYes91 (79.8)
1-blocker91 (79.8)
Anticholinergic agent9 (7.9)

50 to 6514 (12.3)
65 to 7014 (12.3)
70 to 7539 (34.2)
Age (yrs)75 to 8027 (23.7)
≥8020 (17.5)
Mean ± SD73.0 ± 6.8
Median73.0
Range (Min–Max)57.0–89.0

≤1.07 (6.5)
>1.0 and ≤2.012 (11.2)
PSA at Week 0 (ng/mL)>2.0 and ≤4.031 (29.0)
>4.0 and ≤6.022 (20.6)
>6.0 and ≤10.031 (29.0)
>10.04 (3.7)
Mean3.66

20 to 3022 (20.2)
30 to 4018 (16.5)
Prostate volume (mL)40 to 5531 (28.4)
55 to 8029 (26.6)
≥809 (8.3)
Mean46.15

PSA: prostate-specific antigen; The day of the first dose.